Next Article in Journal
Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways
Next Article in Special Issue
Transcriptome Profiling in Human Diseases: New Advances and Perspectives
Previous Article in Journal
Transcriptome Differences in Porcine Alveolar Macrophages from Tongcheng and Large White Pigs in Response to Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection
Previous Article in Special Issue
Transcriptomics, NF-κB Pathway, and Their Potential Spaceflight-Related Health Consequences
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(7), 1497;

lncRNAs and MYC: An Intricate Relationship

Hematopathology Section, University Hospital Schleswig-Holstein Campus Kiel, Christian-Albrechts University, D-24105 Kiel, Germany
Institute of Genetics and Biophysics, “A. Buzzati-Traverso”, Consiglio Nazionale delle Ricerche, I-80131 Naples, Italy
Received: 21 June 2017 / Revised: 5 July 2017 / Accepted: 11 July 2017 / Published: 12 July 2017
(This article belongs to the Special Issue Transcriptome Profiling in Human Diseases)
Full-Text   |   PDF [555 KB, uploaded 12 July 2017]   |  


Long non-coding RNAs (lncRNAs) are emerging as important regulators of gene expression networks, acting either at the transcriptional level, by influencing histone modifications, or at the post-transcriptional level, by controlling mRNA stability and translation. Among the gene expression networks known to influence the process of oncogenic transformation, the one controlled by the proto-oncogene MYC is one of the most frequently deregulated in cancer. In B-cell lymphomas, the MYC gene is subject to chromosomal rearrangements that result in MYC overexpression. In many other cancers, the region surrounding MYC is subject to gene amplification. MYC expression is also controlled at the level of protein and mRNA stability. Neoplastic lesions affecting MYC expression are responsible for a drastic change in the number and the type of genes that are transcriptionally controlled by MYC, depending on differential promoter affinities. Transcriptome profiling of tumor samples has shown that several lncRNAs can be found differentially regulated by MYC in different cancer types and many of them can influence cancer cell viability and proliferation. At the same time, lncRNAs have been shown to be able to control the expression of MYC itself, both at transcriptional and post-transcriptional levels. Given that targeting the MYC-dependent transcriptional program has the potential to reach broad anticancer activity, molecular dissection of the complex regulatory mechanisms governing MYC expression will be crucial in the future for the identification of novel therapeutic strategies. View Full-Text
Keywords: MYC; lncRNAs; transcriptome profiling; cancer; transcription regulation MYC; lncRNAs; transcriptome profiling; cancer; transcription regulation

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Iaccarino, I. lncRNAs and MYC: An Intricate Relationship. Int. J. Mol. Sci. 2017, 18, 1497.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top